Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • rexmundiz rexmundiz Jul 5, 2006 7:05 PM Flag

    WALK DOWN

     

    in order to buy back by the same coward fund managers wbasdurds seek. ho trashed the stock in the first place. i recomend you all to sell tomorrow in order to obtain same low price as these . lets get this turd down hard.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • and i am your daddy to, take some prozac

    • You are not only a joke, you are probably beach and coldpizza.

    • so whats your point?

      What do short shares have to do with anything, last I looked Sepracor was trading mid $50s down from a big run to $61, NBIX is trading at $10 down from $73, so what is your point.

      The P2 pipeline Insomnia drug made it a get out of town decision for Pfizer to drop Indiplon. lots of unknows about 15Mg as their is no longterm trial data. long slogg to market if ever.

      Minor adverse event according to the FDA site.
      all Adverse events no matter how minor from a clinical trial is on the public record and placed in the label. Again what is your point?

      go back to sleep.

    • - so the sleep market is going to move to short acting treatments to help people fall asleep and then re-dose if they wake up - ( the second part of the IR application - the middle of the night dose - remember you cannot take ambien or lunesta unless you have 8 hours or more to sleep if you wake up in the middle of the night you are toast - not so with indiplon - so i think you should go out and talk to a few docs that have older patients that have problems sleeping - the one i have talked to have told me that they try people who have taken ambien on lunesta and it almost never works and those folks are impaired in the morning - they want a shorting acting drug with the impairment or the addiction problems of ambien and lunesta - and yikes - nobody wants the cancer risk of lunesta - as you have seen 4 FDA reviewers didn't even want lunesta near the US market

    • Agree, waiting for nice re-entry point. Would love to get back in the 15s. ELN has been a traders dream. Sell into almost any rally and you can always buy back lower.

 
NBIX
52.9804+1.4804(+2.87%)1:28 PMEDT